Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
Digestive Diseases and Sciences|September 27, 2005
Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expressionTetsuro Hiratsuka, Seiji Futagami, Tomotaka Shindo, et al.Digestion|September 26, 2017
Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto ClassificationYasuhiro Kodaka, Seiji Futagami, Atsushi Tatsuguchi, et al.Journal of Gastroenterology and Hepatology|November 24, 2012
Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotypeNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 23, 2014
Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotypeHiroshi Abe, Akihito Tsubota, Noritomo Shimada, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 4, 2013
Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascitesYasuhiko Taki, Hidenori Kanazawa, Yoshiyuki Narahara, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2009
[Transjugular intrahepatic portosystemic shunt for refractory ascites: results in 50 patients]Hidenori Kanazawa, Yoshiyuki Narahara, Takeshi Fukuda, et al.Gastroenterology Research and Practice|September 9, 2014
Predictors of response to 24-week telaprevir-based triple therapy for treatment-naïve genotype 1b chronic hepatitis C patientsHiroshi Abe, Akihito Tsubota, Noritomo Shimada, et al.United European Gastroenterology Journal|June 12, 2014
Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trialHidekazu Suzuki, Hiroaki Kusunoki, Takeshi Kamiya, et al.Journal of Gastroenterology and Hepatology|May 19, 2006
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipideAkira Terano, Tetsuo Arakawa, Toshiro Sugiyama, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 29, 2013
Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissuesHiroyuki Nagoya, Seiji Futagami, Mayumi Shimpuku, et al.Pageof 15